🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Vegetarian Softgel(s) Serving Size
90 Servings
Vitamin Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

500 mcg (417% DV)
📊 4.2× RDA — above typical dose 📚 273 studies (Tier A: 9, B: 175)
RDA 0.12mg This product: 0.5mg
100 mcg (83% DV)
✅ Within RDA (0.8× RDA of 0.12 mg) 📚 273 studies (Tier A: 9, B: 175)
RDA 0.12mg This product: 0.1mg

Other Ingredients

Tapioca Starchgel, Modified Glycerin Water, Purified Extra Virgin Olive Oil

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (100% of products) Structure/Function (84% of products) Nutrient (73% of products)

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Suggested use: Adults take 1 softgel daily with food, or as recommended by your healthcare provider.

⚠️ Warnings & Precautions

Discontinue use 2 weeks prior to surgery. NatureWise vitamin K2 should always be taken in conjunction with a healthy diet and regular exercise program.

Caution: As with any dietary supplement, you should consult your healthcare provider before use, especially if pregnant, nursing, have a medical condition, taking medications, or have known adverse reactions or allergies.

Caution: As with any dietary supplement, you should consult your healthcare provider before use, especially if pregnant, nursing, have a medical condition, taking medications, or have known adverse reactions or allergies.

Warning: Contains vitamin K2.

Warfarin statement: Do not use with Warfarin (coumadin) unless under the care of a physician

Keep out of the reach of children.

Do not use if safety seal is damaged or missing.

🧪 Formulation Notes

Vegan

Gluten free Dairy free

100 mcg MK-7 + 500 mcg MK-4 The human body uses vitamin K to produce a protein called prothrombin, which plays an essential role in blood clotting and helps maintain bone mineral density. Vitamin K2 promotes heart health by preventing calcium buildup in the blood vessels, and its antioxidant properties help protect cells from free radical damage. It also supports energy production and normal blood glucose levels. Menaquinone-7, a subtype of vitamin K2, is the most bioavailable of the menaquinones and has demonstrated the greatest bone building benefits.

MK-7 & MK-4 Formulated with VitaMK7, the most advanced vitamin K2 Menaquinone-7

Supports calcium uptake and bone mineralization

This product does not contain: wheat, gluten, dairy, eggs, tree nuts, peanuts, fish, shellfish, yeast, soy, fillers, or binders.

Additional Information

To learn more about NatureWise vitamin K2 and our other great products, please visit us at naturewise.com.

Store in a cool, dry place.

Product Details

UPC / SKU 8 55724 00759 6
DSLD Entry Date 2025-03-25
Product Type Vitamin
Form Softgel Capsule
Brand NatureWise
DSLD ID 327761
Data Updated 2026-04-11

Research Evidence

332 Research Sources
59 Avg Quality Score
220 Meta Analysis
56 Systematic Review
30 Rct
16 Clinical Trial
3 Guideline
3 Regulatory Source
1 Narrative Review
1 Other
1 Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014
View all evidence for Vitamin K →

Compare Similar Products

View all Vitamin K products →